Cargando…
Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides: The First Double-Blind, Randomized, Controlled Trial in Pre-term Infants
There is growing evidence supporting the benefit of human milk oligosaccharides (HMOs) on reducing risk of illnesses and improving immune function in newborn infants, but evidence in pre-term infants is lacking. This randomized, double-blind, placebo-controlled trial (NCT03607942) of pre-term infant...
Autores principales: | Hascoët, Jean-Michel, Chevallier, Marie, Gire, Catherine, Brat, Roselyne, Rozé, Jean-Christophe, Norbert, Karine, Chen, Yipu, Hartweg, Mickaël, Billeaud, Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119431/ https://www.ncbi.nlm.nih.gov/pubmed/35601412 http://dx.doi.org/10.3389/fped.2022.858380 |
Ejemplares similares
-
Comparative study of preterm infants fed new and existing human milk fortifiers showed favourable markers of gastrointestinal status
por: Rigo, Jacques, et al.
Publicado: (2019) -
Immunological Effects of Human Milk Oligosaccharides
por: Triantis, Vassilis, et al.
Publicado: (2018) -
Infants Are Exposed to Human Milk Oligosaccharides Already in utero
por: Wise, Audra, et al.
Publicado: (2018) -
Dynamics of human milk oligosaccharides in early lactation and relation with growth and appetitive traits of Filipino breastfed infants
por: Samuel, Tinu M., et al.
Publicado: (2022) -
Processing of Donor Human Milk: Update and Recommendations From the European Milk Bank Association (EMBA)
por: Moro, Guido E., et al.
Publicado: (2019)